The boom in weight loss products has long since spread to the stock markets. While the shares of pharmaceutical companies Novo Nordisk and Eli Lilly are benefiting from the high demand, other industry giants are also looking to follow. However, experts are also warning of possible side effects of the drugs, which were originally developed to treat diabetes.
LATEST CONTRIBUTIONS
Interest rate cuts and economic growth – a favourable environment for the markets
Even though the ECB recently left its key interest rate unchanged, central banks are increasingly signaling an inclination to cut interest rates for the first time. At the same time, the indicators point to good economic growth at a global level. These are positive signals for the stock markets.
Is this time different?
The risk premiums on corporate bonds are close to their lows. What are the reasons? Is a correction imminent or is everything perhaps completely different on the bond market this time?
What is the key interest rate?
Ahead of the ECB’s upcoming interest rate decision, there is much discussion about the central banks’ interest rate policy and the key interest rate – will it be lowered or not? Its development has a significant influence on the economy and the financial markets. In this article, we discuss the role of the key interest rate and which interest rates are relevant.
Swimming against the tide with alternative investments
Alternative investment strategies are not comparable with traditional asset classes such as equities or bonds – this is precisely their charm. But how do these strategies work and how can investors invest in them?
AI Boom Yields Strong Quarterly Gains for US Tech Giants
The topic of artificial intelligence continues to flourish on the stock market. The US chip company Nvidia recently attracted attention with another strong set of quarterly figures. How did the rest of the “Magnificent Seven” fare in the reporting season and what are the plans of the tech giants in the AI sector?
Money tip: Are biotechnology stocks at the outset of a new upswing?
Biotechnology stocks have been back in the spotlight since the beginning of the year. Successes in research and market approvals for new drugs could provide fresh impetus. Is the sector worth a look now?
Corporate bonds – Why emerging markets are worth a look
Fund manager Thomas Oposich explains in an interview what makes investments in emerging market bonds interesting and which sectors and companies he considers promising.
Stock market at all-time high: What are the reasons?
Several important stock indices have recently reached new record highs. What are the reasons for the positive sentiment, what could move the markets this year and what about the much-cited Magnificent 7?
Global Economy: IMF with more positive outlook
According to the IMF, the global economy could grow more strongly than expected this year. In the US and China, the economy is likely to remain robust, although growth in the People’s Republic is likely to weaken. The experts are less optimistic about the German economy.